Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Gain Therapeutics, Inc. | Chief Executive Officer, Director | Common Stock | 21.1K | $85.8K | $4.06 | Mar 26, 2024 | Direct |
Gain Therapeutics, Inc. | Chief Executive Officer, Director | Restricted Stock Units | 6.38K | $24.6K | $3.86 | Mar 26, 2024 | Direct |
Gain Therapeutics, Inc. | Chief Executive Officer, Director | Employee Stock Option (right to buy) | 370K | Mar 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GANX | Gain Therapeutics, Inc. | Mar 26, 2024 | 7 | -$24.7K | 4 | Mar 28, 2024 | Chief Executive Officer, Director |
GANX | Gain Therapeutics, Inc. | Mar 21, 2024 | 1 | $0 | 4 | Mar 25, 2024 | Chief Executive Officer, Director |
GANX | Gain Therapeutics, Inc. | Dec 20, 2023 | 3 | -$507 | 4 | Dec 22, 2023 | Chief Executive Officer, Director |
GANX | Gain Therapeutics, Inc. | Dec 7, 2023 | 1 | -$4.55K | 4 | Dec 14, 2023 | Chief Executive Officer, Director |
GANX | Gain Therapeutics, Inc. | Oct 1, 2023 | 2 | $0 | 4 | Oct 3, 2023 | Chief Executive Officer, Director |
GANX | Gain Therapeutics, Inc. | Sep 20, 2023 | 2 | $0 | 4 | Sep 22, 2023 | Chief Executive Officer, Director |
GANX | Gain Therapeutics, Inc. | Jul 1, 2023 | 2 | $0 | 4 | Jul 5, 2023 | Chief Executive Officer, Director |
GANX | Gain Therapeutics, Inc. | Mar 23, 2023 | 2 | $0 | 4 | Mar 27, 2023 | Chief Executive Officer, Director |
GANX | Gain Therapeutics, Inc. | Sep 20, 2022 | 2 | $0 | 4 | Sep 22, 2022 | Chief Operating Officer, Director |
GANX | Gain Therapeutics, Inc. | Jul 15, 2022 | 2 | $0 | 4 | Jul 19, 2022 | Chief Operating Officer |
GANX | Gain Therapeutics, Inc. | Dec 23, 2021 | 1 | $1.17M | 4 | Dec 28, 2021 | CHIEF OPERATING OFFICER |
GANX | Gain Therapeutics, Inc. | Dec 23, 2021 | 0 | $0 | 3 | Dec 28, 2021 | CHIEF OPERATING OFFICER |